Erasca, Inc. Files 8-K Report

Ticker: ERAS · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1761918

Sentiment: neutral

Topics: sec-filing, 8-k, regulatory-disclosure

TL;DR

Erasca filed an 8-K, likely containing regulatory updates and financial info.

AI Summary

On January 13, 2025, Erasca, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the filing of Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.

Why It Matters

This filing indicates Erasca, Inc. is providing updates or disclosures to the SEC, which could contain important information for investors regarding financial status or regulatory compliance.

Risk Assessment

Risk Level: low — The provided excerpt is a standard SEC filing notification and does not contain specific material events or financial data that would indicate a change in risk.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Erasca, Inc.?

The filing is primarily for Regulation FD Disclosure and the submission of Financial Statements and Exhibits.

On what date was this 8-K report filed or effective?

The report was filed as of January 13, 2025.

In which U.S. state is Erasca, Inc. incorporated?

Erasca, Inc. is incorporated in Delaware.

What is the SEC file number for Erasca, Inc.?

The SEC file number for Erasca, Inc. is 001-40602.

Where are Erasca, Inc.'s principal executive offices located?

Erasca, Inc.'s principal executive offices are located in San Diego, California.

Filing Stats: 748 words · 3 min read · ~2 pages · Grade level 11.7 · Accepted 2025-01-13 09:10:29

Key Financial Figures

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On January 13, 2025, Erasca, Inc. (the Company) updated its corporate presentation to reflect certain business and strategic updates. The updated corporate presentation is attached as Exhibit 99.1 to this report, and is incorporated herein by reference. On January 14, 2025, representatives of the Company will be presenting at the J.P. Morgan Healthcare Conference and will be attending meetings with investors and analysts during the week in connection with the conference. During the presentation and the meetings the Company will present the updated corporate presentation. The Company's updated corporate presentation will be posted to the Company's website, www.erasca.com. The Company plans to use its website to disseminate future updates to its corporate presentation and does not intend to file or furnish a Form 8-K alerting investors each time the presentation is updated. The information set forth in this Item 7.01 is being furnished pursuant to Item 7.01 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, and it shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or under the Exchange Act, whether made before or after the date hereof, except as expressly provided by specific reference in such a filing. By filing this report and furnishing the information in this Item 7.01, the Company makes no admission as to the materiality of Item 7.01 in this report or the presentation available on the Company's website. The information contained in the presentation is summary information that is intended to be considered in the context of the Company's filings with the Securities and Exchange Commission (the SEC) and other public announcements that the Company makes, by press release or otherwise, from time to time. The Company undertakes no duty or

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Erasca Corporate Presentation January 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Erasca, Inc. Date: January 13, 2025 By: /s/ Ebun Garner General Counsel

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing